Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 04/1/22 → 03/31/24 |
Funding
- Medpace LLC: $8,750.00
Summit Therapeutics: A Randomized, Double Blind, Active Controlled Study to Evaluate the Safety and Tolerability of Ridinilazole Compared with Vancomycin and to Assess the Pharmacokinetics of Ridinilazole in Adolescent Subjects (Aged 12 to
- Handel, Andrew (PI)
- Beneri, Christy (CoPI)
- Nachman, Sharon (CoPI)
Project: Research